Buys | $1,490 | 2 | 100 |
Sells | $0 | 0 | 0 |
Bitterman Robert J | President & CEO | 2 | $1,490 | 0 | $0 | $1,490 |
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that …
Over the last 12 months, insiders at Phio Pharmaceuticals Corp. have bought $1,490 and sold $0 worth of Phio Pharmaceuticals Corp. stock.
On average, over the past 5 years, insiders at Phio Pharmaceuticals Corp. have bought $10,671 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bitterman Robert J (President & CEO) — $1,490.
The last purchase of 1,000 shares for transaction amount of $740 was made by Bitterman Robert J (President & CEO) on 2024‑06‑07.
2024-06-07 | Bitterman Robert J | President & CEO | 1,000 0.0216% | $0.74 | $740 | -58.12% | ||
2024-06-06 | Bitterman Robert J | President & CEO | 1,000 0.0218% | $0.75 | $750 | -58.37% | ||
2024-02-26 | Bitterman Robert J | President & CEO | 2,500 0.0539% | $0.91 | $2,275 | -60.89% | ||
2023-07-01 | Bitterman Robert J | President & CEO | 1,000 0.0866% | $2.84 | $2,840 | -48.79% | ||
2023-06-30 | Bitterman Robert J | President & CEO | 1,000 0.0879% | $2.88 | $2,880 | -67.89% | ||
2023-06-14 | Ferrara Robert L | director | 2,000 0.1723% | $3.10 | $6,200 | -69.59% | ||
2022-12-14 | Bitterman Robert J | Interim Executive Chairman | 2,000 0.015% | $0.39 | $780 | -34.24% | ||
2022-12-07 | Bitterman Robert J | Interim Executive Chairman | 2,000 0.0149% | $0.39 | $780 | -31.77% | ||
2022-12-05 | Bitterman Robert J | Interim Executive Chairman | 2,000 0.0156% | $0.43 | $860 | -34.98% | ||
2022-12-02 | Ferrara Robert L | director | 5,000 0.0377% | $0.41 | $2,041 | -32.25% | ||
2022-11-29 | Bitterman Robert J | Interim Executive Chairman | 215 0.0016% | $0.40 | $86 | -31.88% | ||
2022-11-25 | Bitterman Robert J | Interim Executive Chairman | 2,500 0.019% | $0.42 | $1,050 | -31.05% | ||
2022-11-23 | Ferrara Robert L | director | 2,000 0.0147% | $0.41 | $820 | -31.71% | ||
2022-11-16 | Bitterman Robert J | Interim Executive Chairman | 1 – | $1,750.00 | $1,750 | -30.57% | ||
2021-08-16 | Dispersyn Gerrit | President & CEO | 6,000 0.0446% | $1.63 | $9,780 | -43.62% | ||
2021-03-04 | Dispersyn Gerrit | President & CEO | 1,953 0.0185% | $2.56 | $5,000 | -26.88% | ||
2021-03-03 | Dispersyn Gerrit | President & CEO | 2,500 0.0241% | $3.03 | $7,575 | -36.39% | ||
2021-03-03 | Ferrara Robert L | director | 682 0.0068% | $3.15 | $2,148 | -36.39% | ||
2020-08-19 | Dispersyn Gerrit | President & CEO | 2,000 0.0345% | $2.50 | $5,000 | -8.96% | ||
2017-10-02 | CAUWENBERGH GEERT | President & CEO | 10,000 0.0428% | $0.45 | $4,475 | -35.40% |
Bitterman Robert J | President & CEO | 20990 0.4394% | $27,077.10 | 14 | 0 | <0.0001% |
Advanced RNA Technologies, LLC | 1221723 25.5759% | $1.58M | 1 | 0 | ||
CAUWENBERGH GEERT | President & CEO | 142583 2.9849% | $183,932.07 | 60 | 0 | |
Dispersyn Gerrit | President & CEO | 95281 1.9946% | $122,912.49 | 5 | 0 | <0.0001% |
Ferrara Robert L | director | 6000 0.1256% | $7,740.00 | 4 | 0 | <0.0001% |
$18,881,323 | 88 | -48.96% | $4.47M | |
$1,159,104 | 40 | -21.75% | $7.98M | |
$296,936 | 37 | -18.12% | $4M | |
$523,320 | 24 | 94.37% | $7.01M | |
$31,129 | 22 | -11.96% | $6.19M |
Increased Positions | 9 | +150% | 151,171 | +530.31% |
Decreased Positions | 2 | -33.33% | 25,631 | -89.91% |
New Positions | 7 | New | 146,951 | New |
Sold Out Positions | 2 | Sold Out | 25,631 | Sold Out |
Total Postitions | 13 | +116.67% | 154,046 | +440.4% |
Citadel Advisors Llc | $63.00 | 0.89% | 44,526 | +44,526 | New | 2024-12-31 |
Hrt Financial Lp | $60.00 | 0.85% | 42,338 | +42,338 | New | 2024-12-31 |
Virtu Financial Llc | $58.00 | 0.82% | 40,910 | +40,910 | New | 2024-12-31 |
Cetera Investment Advisers | $18.00 | 0.26% | 13,000 | +13,000 | New | 2024-12-31 |
Morgan Stanley | $8.00 | 0.12% | 5,911 | +5,911 | New | 2024-12-31 |
Tower Research Capital Llc (Trc) | $7.00 | 0.09% | 4,682 | +3,508 | +298.81% | 2024-12-31 |
Ubs Group Ag | $3.00 | 0.05% | 2,397 | +712 | +42.26% | 2024-12-31 |
Barclays Plc | $0 | <0.01% | 203 | +203 | New | 2024-12-31 |
Sbi Securities Co., Ltd. | $0 | <0.01% | 63 | +63 | New | 2024-12-31 |
Activest Wealth Management | $0 | 0% | 9 | 0 | 0% | 2024-12-31 |